Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00258206 · OUTCOME

Complete Response (CR) Rate and Partial Response (PR) Rate

Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma · Source last updated 2017-12-06

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
1 year

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
reporting Status
NOT_POSTED
time Frame
1 year
title
Complete Response (CR) Rate and Partial Response (PR) Rate
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice